A 5-year-old boy presents with a 3-day history of high fever, red eyes (conjunctivitis),…
- User
A 5-year-old boy presents with a 3-day history of high fever, red eyes (conjunctivitis), a rash, and red, cracked lips. He also has swollen lymph nodes in his neck. What is the most likely diagnosis? Why is it critical to treat this condition promptly with intravenous immunoglobulin (IVIG) and aspirin, and what is the major cardiovascular complication the treatment aims to prevent?
- Assistant
Most likely diagnosis: Kawasaki disease.
Diagnostic Reasoning
This presentation is textbook incomplete Kawasaki disease (or atypical KD), meeting key clinical features in a child under 5 years (peak incidence 6–24 months, but common up to age 5):
- Persistent high fever (≥5 days required for complete KD, but ≥3–4 days prompts evaluation for incomplete cases).
- Bilateral non-exudative conjunctivitis ("red eyes").
- Oral mucosal changes (red, cracked lips; often with strawberry tongue).
- Polymorphous rash (typically morbilliform or scarlatiniform).
- Cervical lymphadenopathy (unilateral >1.5 cm, least common but present here).
Diagnosis is clinical (no specific test); supported by elevated CRP/ESR, thrombocytosis, and exclusion of mimics (e.g., scarlet fever, measles, adenovirus). Echo or labs (e.g., low albumin, anemia) confirm if incomplete.
Why Prompt Treatment with IVIG + Aspirin?
- Critical timing: Administer IVIG 2 g/kg as single infusion + high-dose aspirin (80–100 mg/kg/day, then low-dose) within 10 days of fever onset (ideally <7 days). Untreated risk of coronary complications is ~25%; treatment drops it to ~5%.
- Mechanism:
- IVIG: Immunomodulatory; neutralizes superantigens/cytokines driving vasculitis.
- Aspirin: Anti-inflammatory (high dose) + antiplatelet (low dose post-fever) to prevent thrombosis.
- Evidence: AHA guidelines; RCTs show 85–95% fever resolution within 36 hours, drastic aneurysm risk reduction.
Major Cardiovascular Complication Prevented
Coronary artery aneurysms/dilatations (in proximal left anterior descending/right coronary arteries). These occur in 15–25% untreated cases, risking:
- Giant aneurysms (>8 mm) → thrombosis/MI/sudden death (5–10% mortality long-term).
- Monitoring: Baseline + serial echocardiography; long-term ASA/antiplatelets/statins if persistent.
Immediate action: Admit, start empiric therapy if suspicion high—delays kill.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.